Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Implementing an Integrated Pharmaceutical Management Information System for Antiretrovirals and Other Medicines: Lessons From Namibia.

Mabirizi D, Phulu B, Churfo W, Mwinga S, Mazibuko G, Sagwa E, Indongo L, Hafner T.

Glob Health Sci Pract. 2018 Dec 27;6(4):723-735. doi: 10.9745/GHSP-D-18-00157. Print 2018 Dec 27.

2.

Digital health technologies to support access to medicines and pharmaceutical services in the achievement of sustainable development goals.

Konduri N, Aboagye-Nyame F, Mabirizi D, Hoppenworth K, Kibria MG, Doumbia S, Williams L, Mazibuko G.

Digit Health. 2018 May 3;4:2055207618771407. doi: 10.1177/2055207618771407. eCollection 2018 Jan-Dec.

3.

Assessment of the World Health Organization's HIV Drug Resistance Early Warning Indicators in Main and Decentralized Outreach Antiretroviral Therapy Sites in Namibia.

Mutenda N, Bukowski A, Nitschke AM, Nakanyala T, Hamunime N, Mekonen T, Tjituka F, Mazibuko G, Mwinga S, Mabirizi D, Sagwa E, Indongo R, Dean N, Jordan MR, Hong SY.

PLoS One. 2016 Dec 1;11(12):e0166649. doi: 10.1371/journal.pone.0166649. eCollection 2016.

4.

Antimicrobial sensitivity patterns of cerebrospinal fluid (CSF) isolates in Namibia: implications for empirical antibiotic treatment of meningitis.

Mengistu A, Gaeseb J, Uaaka G, Ndjavera C, Kambyambya K, Indongo L, Kalemeera F, Ntege C, Mabirizi D, Joshi MP, Sagwa E.

J Pharm Policy Pract. 2013 Jun 13;6:4. doi: 10.1186/2052-3211-6-4. eCollection 2013.

5.

Records linkage of electronic databases for the assessment of adverse effects of antiretroviral therapy in sub-Saharan Africa.

Corbell C, Katjitae I, Mengistu A, Kalemeera F, Sagwa E, Mabirizi D, Lates J, Nwokike J, Fuller S, Stergachis A.

Pharmacoepidemiol Drug Saf. 2012 Apr;21(4):407-14. doi: 10.1002/pds.2252. Epub 2011 Oct 19.

PMID:
22009899

Supplemental Content

Loading ...
Support Center